Impact of the Affordable Care Act on Insurance Status of Patients Newly Diagnosed With Kaposi Sarcoma

Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 2

Abstract

Background: The Affordable Care Act (ACA) role in changing the insurance composition of patients diagnosed with many dermatological conditions, such as Kaposi Sarcoma (KS), has not been assessed. Methods: The Surveillance, Epidemiology and End Results (SEER) Program, which captures cancer data from nearly 40% of cases in the US was used to extract cases. Cases were subgrouped by Medicaid expansion and non-expansion states. Standard mean differences were used as the statistical measure with P-value <0.05 used for statistical significance. Results: 2,465 patients met the inclusion criteria. In patients newly diagnosed with Kaposi sarcoma nationally before and after ACA implementation, the analysis showed there was no significant difference in the percentage of uninsured patients, Medicaid-insured patients, or privately insured patients. Pre- and post-ACA sub-analysis of patients newly diagnosed with Kaposi sarcoma in states that expanded Medicaid showed: (1) significant decrease in the percentage of uninsured patients (-5.81% difference, 95% CI -9.58% to -2.04%, P <.05); (2) significant increase in the percentage of Medicaid-insured patients (+9.36% difference, 95% CI +0.35% to +18.37%, P <.05) and (3) no significant difference in the percent of privately insured patients (-3.54% difference, 95% CI -13.74% to +6.64%). Sub-analysis in non-expansion states showed no difference between the insurance subtypes. Conclusion: Medicaid expansion played the largest role in reducing the percentage of uninsured patients newly diagnosed with KS. In states without Medicaid expansion, it is important that public health forces ensure adequate access to medications with services like the Ryan White HIV/AIDS Program.

Authors and Affiliations

Vignesh Ramachandran, Esha Hansoti

Keywords

Related Articles

Severe Sunburn as the Overwhelming Risk Factor for 3 Common Skin Cancers: New Prevention Strategy

Re-analysis of published data from two large prospective cohort studies by Wu et al provides hitherto most unequivocal evidence showing Severe Sunburn (SS) as an overwhelming risk factor (> 90%) for all incidences of m...

Recent Highlights and Expert Opinion on Psoriasis Management

Psoriasis is a common chronic inflammatory skin disorder characterized by red, flaky, crusty, scaly, itchy, thickened plaques (Fig. 1), which affects approximately 2% of the population worldwide [1-2]. Increasing evide...

Improvements in Skin and Nail Psoriasis are Positively Correlated across Systemic Psoriasis Therapies

Objective: For clinical scenarios where patients have moderate to severe psoriasis and nail psoriasis, knowing whether skin response is correlated with nail response would provide insight into the relationship between ps...

Human Hair Care Using Products Containing Naturally Obtained Collagen from Salmon Skin Waste

The aim of the articles was to popularize the upcycling trend in the production of sustainable cosmetics and to confirm their effectiveness. For thousands of years, people have been looking for new ways to improve their...

Cutaneous Drug Eruption after COVID-19 Vaccination

The SARS-CoV-2 virus is a highly transmissible virus that has infected millions of people globally over the past year. In the United States alone, over 400,000 deaths have been reported due to COVID-19 infection [1]. I...

Download PDF file
  • EP ID EP717152
  • DOI https://doi.org/10.46889/JDR.2023.4204
  • Views 45
  • Downloads 0

How To Cite

Vignesh Ramachandran, Esha Hansoti (2023). Impact of the Affordable Care Act on Insurance Status of Patients Newly Diagnosed With Kaposi Sarcoma. Journal of Dermatology Research, 4(2), -. https://europub.co.uk/articles/-A-717152